In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Myriad Genetics, Inc (NASDAQ: MYGN) was $4.92 for the day, down -2.19% from the previous closing price of $5.03. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 1.17 million shares were traded.
Ratios:
Our analysis of MYGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Wells Fargo Downgraded its Overweight to Equal Weight on May 07, 2025, while the target price for the stock was maintained at $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 0.64.
Stock Price History:
Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -16.41%, while the 200-Day Moving Average is calculated to be -65.46%.
Shares Statistics:
A total of 92.20M shares are outstanding, with a floating share count of 87.40M. Insiders hold about 5.19% of the company’s shares, while institutions hold 102.41% stake in the company.
